Skip to main content
Ravi Kane
Ravi Kane
Garry Betty/V Foundation Chair and GRA Eminent Scholar in Cancer Nanotechnology
EBB 5019
Research Interests:

Kane’s research lies at the interface of biotechnology and nanotechnology. His group is designing nanoscale polyvalent therapeutics and working on the molecular engineering of biosurfaces and nanostructures. Kane was previously named by MIT’s Technology Review as one of the TR100 – the top 100 young innovators in the world. 








Read Next:

Allison Lab Discovers Evidence of Multicellularity in Single Cell Organism

Microscale Single Cell Cancer Metabolism Research Earns Honor for Coulter BME Assistant Professor